Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 114.10K | 290.70K | 469.20K | 621.50K | 770.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 114.10K | 290.70K | 469.20K | 621.50K | 770.20K |
| Cost of Revenue | 28.60K | 69.10K | 110.10K | 144.30K | 177.50K |
| Gross Profit | 85.40K | 221.40K | 358.90K | 477.10K | 592.60K |
| SG&A Expenses | 18.50M | 20.65M | 22.72M | 25.50M | 28.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00 | 37.20K | 73.20K | 35.60K | 400.00 |
| Total Operating Expenses | 20.35M | 23.25M | 26.08M | 29.46M | 32.66M |
| Operating Income | -20.24M | -22.96M | -25.61M | -28.83M | -31.89M |
| Income Before Tax | -48.02M | -38.75M | -29.02M | -31.96M | -34.71M |
| Income Tax Expenses | 303.30K | 344.80K | 385.20K | 445.70K | 503.50K |
| Earnings from Continuing Operations | -48.33 | -39.10 | -29.40 | -32.40 | -35.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.33M | -39.10M | -29.40M | -32.40M | -35.22M |
| EBIT | -20.24M | -22.96M | -25.61M | -28.83M | -31.89M |
| EBITDA | -19.91M | -22.60M | -25.23M | -28.45M | -31.51M |
| EPS Basic | -1.25 | -1.13 | -0.99 | -1.16 | -1.32 |
| Normalized Basic EPS | -0.78 | -0.70 | -0.61 | -0.71 | -0.81 |
| EPS Diluted | -1.25 | -1.13 | -0.99 | -1.16 | -1.32 |
| Normalized Diluted EPS | -0.78 | -0.70 | -0.61 | -0.71 | -0.81 |
| Average Basic Shares Outstanding | 147.00M | 134.09M | 121.18M | 114.14M | 107.10M |
| Average Diluted Shares Outstanding | 147.00M | 134.09M | 121.18M | 114.14M | 107.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |